Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis Persistence and Coverage in Men Who Have Sex With Men in France: a Randomized Controlled Clinical Trial.

NCT06273943 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT06273943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis Persistence and Coverage in Men Who Have Sex With Men in France: a Randomized Controlled Clinical Trial.
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 1, 2024
Completion date
October 30, 2026
Enrollment
322 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prevention